Speaker: Aimad Torqui – MSD
Chair: Colette Shortt, MSc,PhD, MBA
Speaker: Elizabeth Scanlan, MSc, PhD – European Medicines Agency
Chair: Colette Shortt, MSc,PhD, MBA
Speaker: Camille Piriou, PharmD – BlueReg
Speaker: Maria Mercedes Bertoli, PhD – Self-employee
Chair: Jennifer Neff, PhD – bess AG
Speaker: Mridula Shukla, Masters in Biotechnology – Arcutis Biotherapeutics Inc.
Chair: Jennifer Neff, PhD – bess AG
Speaker: Kristina Larsson, MSc – European Medicines Agency
Session Leader: Siegfried Schmitt, PhD CSci CChem FRSC – Parexel
Speaker: Stephanie O. Omokaro, MD – U.S. Food & Drug Administration
Speaker: Anthony Humphreys – European Medicines Agency
Session Leader/Speaker: Mridula Shukla, Masters in Biotechnology – Arcutis Biotherapeutics Inc.
Speaker: Patrick Celis, PhD – European Medicines Agency
Session Leader/Speaker: Peter Lassoff, PharmD – Syneos Health
Speaker: John S. Klein, MS MBA – NorthCoast Clinical Consulting, LLC
Speaker: Siegfried Schmitt, PhD CSci CChem FRSC – Parexel
Session Leader: Peter Lassoff, PharmD – Syneos Health
Session Leader/Speaker: Tracy Meffen, MS, CQA, RAC – Genevant Sciences
Speaker: Andreas N. Kuhn, Dr – BioNTech RNA Pharmaceuticals GmbH
Speaker: Ana Hidalgo-Simon, MD, PhD – European Medicines Agency
Speaker: Yingying Liu, M.Sc. – CSL Behring
Chair: Pallavi Trivedi, MPH, RAC – Trident Pharmaceuticals limited & Spinos Clinical Research Uk
Speaker: Stefanie Faßhauer, MBA – PharmaLex
Chair: Pallavi Trivedi, MPH, RAC – Trident Pharmaceuticals limited & Spinos Clinical Research Uk
Speaker: David Thompson, N/A – Clarity compliance solutions ltd
Speaker: Siegfried Schmitt, PhD CSci CChem FRSC – Parexel
Speaker: Irena Milobratovic, MPharm, RAC – Arriello
Speaker: Claudia Louati, MS – US Food and Drug Administration, Europe Office
Speaker: Gabriela Marton – Arriello s.r.o
Chair: Jennifer Neff, PhD – bess AG
Session Leader/Speaker: Charlie Mortazavi, PharmD – SANOFI
Speaker: Mark Louis Slisz, US & EU RAC – Pearl Pathways
Chair: Charlie Mortazavi, PharmD – SANOFI
Speaker: Robert Seevers, PhD – Pearl Pathways
Chair: Mark Di Cioccio – Team Consulting
Chair: Mark Di Cioccio – Team Consulting
Speaker: Philip M. Budashewitz, RPh MA – U.S. Food and Drug Administration